Adding immune-checkpoint inhibitors to chemotherapy extends survival in endometrial cancer

被引：3
|
作者：
Romero, Diana
机构：
[1] Nature Reviews Clinical Oncology,
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2023年 / 20卷 / 06期
关键词：
D O I：
10.1038/s41571-023-00763-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：353 / 353
页数：1
相关论文
共 50 条
  • [11] Immune checkpoint inhibitors for recurrent endometrial cancer
    Mutlu, Levent
    Harold, Justin
    Tymon-Rosario, Joan
    Santin, Alessandro D.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2022, 22 (03) : 249 - 258
  • [12] Beyond current immune-checkpoint inhibitors
    Torigoe, Toshihiko
    Chung, Junho
    CANCER SCIENCE, 2018, 109 : 622 - 622
  • [13] Immune-checkpoint inhibitors in pituitary malignancies
    Di Nunno, Vincenzo
    Franceschi, Enrico
    Tosoni, Alicia
    Gatto, Lidia
    Maggio, Ilaria
    Lodi, Raffaele
    Bartolini, Stefania
    Brandes, Alba A.
    ANTI-CANCER DRUGS, 2022, 33 (01) : E28 - E35
  • [14] Radiation in combination with immune-checkpoint inhibitors
    Mayor, Susan
    LANCET ONCOLOGY, 2015, 16 (04): : E162 - E162
  • [15] Hallmarks of Resistance to Immune-Checkpoint Inhibitors
    Karasarides, Maria
    Cogdill, Alexandria P.
    Robbins, Paul B.
    Bowden, Michaela
    Burton, Elizabeth M.
    Butterfield, Lisa H.
    Cesano, Alessandra
    Hammer, Christian
    Haymaker, Cara L.
    Horak, Christine E.
    McGee, Heather M.
    Monette, Anne
    Rudqvist, Nils-Petter
    Spencer, Christine N.
    Sweis, Randy F.
    Vincent, Benjamin G.
    Wennerberg, Erik
    Yuan, Jianda
    Zappasodi, Roberta
    Lucey, Vanessa M. Hubbard
    Wells, Daniel K.
    LaVallee, Theresa
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (04) : 372 - 383
  • [16] Immune-Checkpoint Inhibitors in Platinum-Resistant Ovarian Cancer
    Indini, Alice
    Nigro, Olga
    Lengyel, Csongor Gyorgy
    Ghidini, Michele
    Petrillo, Angelica
    Lopez, Salvatore
    Raspagliesi, Francesco
    Trapani, Dario
    Khakoo, Shelize
    Bogani, Giorgio
    CANCERS, 2021, 13 (07)
  • [17] Immune-Checkpoint Inhibitors in Advanced Bladder Cancer: Seize the Day
    Maiorano, Brigida Anna
    De Giorgi, Ugo
    Ciardiello, Davide
    Schinzari, Giovanni
    Cisternino, Antonio
    Tortora, Giampaolo
    Maiello, Evaristo
    BIOMEDICINES, 2022, 10 (02)
  • [18] TRANSCRIPTOMIC CHANGES IN CANCER PATIENTS TREATED WITH IMMUNE-CHECKPOINT INHIBITORS
    Shek, Dmitrii
    Gao, Bo
    Lai, Joey
    Yoon, Won-Hee
    Moujaber, Tania
    Nagrial, Adnan
    Carlino, Matteo
    Read, Scott
    Ahlenstiel, Golo
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 : A552 - A552
  • [19] Economic analyses of immune-checkpoint inhibitors to treat lung cancer
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (03) : 365 - 371
  • [20] CLOSTRIDIOIDES DIFFICILE INFECTIONS IN CANCER PATIENTS ON IMMUNE-CHECKPOINT INHIBITORS
    Vasavada, Shaleen
    Amin, Rajan
    Okhuysen, Pablo C.
    Thomas, Anusha Shirwaikar
    Wang, Yinghong
    GASTROENTEROLOGY, 2021, 160 (06) : S50 - S51
12345